CAMPENNI', Alfredo
 Distribuzione geografica
Continente #
EU - Europa 18.892
NA - Nord America 12.527
AS - Asia 7.082
SA - Sud America 2.374
Continente sconosciuto - Info sul continente non disponibili 553
AF - Africa 221
OC - Oceania 19
Totale 41.668
Nazione #
US - Stati Uniti d'America 12.233
RU - Federazione Russa 7.509
IT - Italia 5.197
SG - Singapore 2.838
BR - Brasile 2.048
CN - Cina 1.990
IE - Irlanda 1.651
SE - Svezia 1.588
HK - Hong Kong 807
DE - Germania 650
FR - Francia 496
VN - Vietnam 414
FI - Finlandia 354
NL - Olanda 352
GB - Regno Unito 332
UA - Ucraina 303
IN - India 295
BD - Bangladesh 137
CA - Canada 134
PL - Polonia 121
AR - Argentina 105
TR - Turchia 85
IQ - Iraq 78
MX - Messico 76
ZA - Sudafrica 76
CZ - Repubblica Ceca 59
PK - Pakistan 53
BE - Belgio 51
JP - Giappone 51
EC - Ecuador 48
AT - Austria 47
CO - Colombia 40
ES - Italia 40
ID - Indonesia 38
UZ - Uzbekistan 37
CL - Cile 34
MA - Marocco 33
CI - Costa d'Avorio 31
VE - Venezuela 31
SA - Arabia Saudita 28
AE - Emirati Arabi Uniti 24
IR - Iran 23
LT - Lituania 22
AZ - Azerbaigian 21
PY - Paraguay 20
UY - Uruguay 19
CH - Svizzera 18
KE - Kenya 18
TN - Tunisia 18
PE - Perù 17
AU - Australia 15
PH - Filippine 15
DZ - Algeria 14
JM - Giamaica 14
KZ - Kazakistan 14
EG - Egitto 13
NP - Nepal 13
CR - Costa Rica 12
MY - Malesia 12
IL - Israele 11
PA - Panama 11
PS - Palestinian Territory 11
AL - Albania 10
BO - Bolivia 10
DO - Repubblica Dominicana 10
JO - Giordania 10
KG - Kirghizistan 10
OM - Oman 10
HN - Honduras 9
NI - Nicaragua 9
PT - Portogallo 9
RO - Romania 9
TH - Thailandia 9
BG - Bulgaria 8
LB - Libano 8
NO - Norvegia 8
BY - Bielorussia 7
GT - Guatemala 7
HU - Ungheria 7
EU - Europa 6
GE - Georgia 6
GR - Grecia 6
LV - Lettonia 6
RS - Serbia 6
XK - ???statistics.table.value.countryCode.XK??? 6
DK - Danimarca 5
HR - Croazia 5
EE - Estonia 4
QA - Qatar 4
SV - El Salvador 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
KH - Cambogia 3
KR - Corea 3
LK - Sri Lanka 3
MD - Moldavia 3
MU - Mauritius 3
NG - Nigeria 3
PR - Porto Rico 3
Totale 41.083
Città #
Moscow 2.161
Ashburn 1.714
Dublin 1.646
Singapore 1.548
Dallas 1.397
Chandler 1.381
Nyköping 862
Hong Kong 801
Beijing 727
San Jose 675
Jacksonville 666
Milan 459
Council Bluffs 416
Rome 399
The Dalles 391
Messina 309
Princeton 275
Los Angeles 265
Lauterbourg 253
Dearborn 246
Medford 240
Munich 239
New York 223
Cambridge 205
Des Moines 201
Ann Arbor 186
Naples 181
São Paulo 164
Boardman 129
Buffalo 126
Ho Chi Minh City 108
Turin 99
Hyderabad 97
Warsaw 97
Turku 94
Bremen 91
Jinan 91
Bari 85
Lancaster 85
Catania 84
Palermo 84
Pune 84
Bologna 82
Redondo Beach 82
Santa Clara 81
Tianjin 80
Hanoi 79
Wilmington 75
Guangzhou 67
Florence 65
Dong Ket 61
Woodbridge 61
Belo Horizonte 56
Rio de Janeiro 55
San Mateo 55
Frankfurt am Main 54
Nanjing 53
Shenyang 53
Brussels 51
Genoa 51
Helsinki 51
Orem 50
Brooklyn 46
Denver 44
Johannesburg 44
Montreal 44
Brasília 43
Houston 42
Atlanta 41
London 41
Columbus 38
Chicago 37
Tokyo 37
Zhengzhou 35
Ningbo 34
Chennai 33
Porto Alegre 32
Seattle 32
Stockholm 32
Tashkent 31
Abidjan 30
Brno 30
Vienna 29
Brescia 28
Nanchang 28
Shenzhen 28
Curitiba 27
Hebei 27
Trieste 27
Changsha 26
Phoenix 26
Toronto 26
Baghdad 25
Cagliari 25
Guarulhos 25
Hangzhou 25
Modena 25
Parma 25
Haikou 24
Salvador 24
Totale 22.062
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.701
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 328
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 280
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 258
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 249
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 246
PRE- AND POSTOPERATIVE CEREBRAL PERFUSION ASSESSMENTS IN CHRONIC SUBDURAL HEMATOMA 243
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 236
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 217
HYPERPARATHYROIDISM FROM MEDIASTINAL PARATIROID ADENOMA. CASE REPORT. 211
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 209
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 208
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 204
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 203
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 202
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 201
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 201
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 200
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 199
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 198
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 197
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 194
Association of parathyroid carcinoma and thyroid disorders: A clinical review 194
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 193
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 190
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 189
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 187
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 185
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 185
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 184
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 183
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 183
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 182
ANALYSIS OF THE FACTORS CONDITIONING THE CLINICAL COURSE OF DIFFERENTIATED THYROID CARCINOMA IN CHILDREN AND YOUNG ADULTS 182
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 182
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 180
HER2 analysis in sporadic thyroid cancer of follicular cell origin 179
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 176
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 175
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 174
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 174
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 174
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 173
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 173
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 173
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 173
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 172
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 171
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 171
Oxidative stress as a key feature of autoimmune thyroiditis: an update 171
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 170
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 169
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 169
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 169
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 168
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 167
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 166
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 165
Abla zione radiometabolica dopo rhTSH del residuo tiroideo post -chirurgico in pazienti con orbitopatia di Graves moderatamente severa e severa 165
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 164
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 163
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 163
Internal Dosimetry of Ellipsoidal Targets: models and applications 161
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 160
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 159
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 159
Hyperthyroidism treatment with calculated activity of 131–radioiodine 159
An uncommon case of Marine-Lenhart syndrome 159
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 158
Iodine-131 treatment of hyperthyroidism: our experience 158
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 157
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 155
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 155
A model for computing absorbed fractions for alpha particles in ellipsoidal volumes 155
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 155
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 154
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 154
Differentiated thyroid carcinoma in lingual thyroid 154
Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan 153
Scintigraphic evaluation of colonic motility in patients with anorectal malformations and constipation 152
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 152
La paratiroidectomia radioguidata 151
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 151
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 151
Advances in Monte Carlo patient-specific internal dosimetry for 90 Y-TARE treatments. 150
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 150
PRRT retreatments: renal function evaluation 150
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 149
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 149
I carcinomi tiroidei differenziati. 148
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 148
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 148
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 148
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 148
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 147
Meningocele mimicking a metastasis of papillary thyroid carcinoma 147
Geriatric primary hyper-parathyrodism 147
An User-Friendly Approach to the Evaluation of Skin and Eye Lens Doses to the Operators in Nuclear Medicine through Dedicated Monte Carlo Simulations in GAMOS 147
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 145
High-grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 145
Totale 22.199
Categoria #
all - tutte 130.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.899 0 247 27 74 62 23 103 100 32 318 283 630
2022/20235.160 395 526 245 381 402 575 78 303 2.006 40 150 59
2023/20242.469 116 181 145 202 162 425 123 150 99 295 192 379
2024/20258.397 312 217 314 595 497 372 387 1.565 1.634 559 741 1.204
2025/202618.371 1.008 1.202 1.418 1.173 1.461 3.739 2.149 2.244 2.312 906 362 397
2026/20271.002 368 634 0 0 0 0 0 0 0 0 0 0
Totale 41.668